Vancomycin 50 mg/mL Suspension in Oral Syrup: Stability in Plastic Bottles and Syringes at 2 Temperatures | Vancomycin Hydrochloride | Oral Syrup | |
Stability of Extemporaneously Compounded Trimethoprim in Glass and Plastic Bottles and Plastic Syringes | Trimethoprim | Oral Mix, Oral Mix, SF | |
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca HRT Cream Base | Testosterone | HRT Cream Base | |
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca VersaPro Cream Base | Testosterone | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca VersaPro Gel Base | Testosterone | VersaPro Gel Base | |
Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes | Tacrolimus | Oral Mix | |
Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes | Sulfamethoxazole, Trimethoprim | Oral Mix, Oral Mix, SF | |
Chemical Stability of Compounded Spironolactone Suspension in Proprietary Oral Mix™ Over a 90-day Period at Two Controlled Temperatures in Different Storage Containers (potency-over-time only) | Spironolactone | Oral Mix | |
Stability of Extemporaneously Compounded Pyridoxine in Glass and Plastic Bottles and Plastic Syringes | Pyridoxine Hydrochloride | Oral Mix, Oral Mix, SF | |
In Vitro Evaluation of the Percutaneous Absorption of Progesterone in Medisca VersaPro Cream Base | Progesterone | VersaPro Cream Base | |
Chemical Stability of Progesterone in Compounded Topical Preparations using PLO Transdermal Cream and HRT Cream Base over a 90-Day Period at Two Controlled Temperatures (potency-over-time only) | Progesterone | PLO Transdermal Cream, HRT Cream Base | |
Stability Assessment of Compounded Bracketed Progesterone 1-40% in Medisca HRT Cream Base | Progesterone | HRT Cream Base | |
Stability Assessment of Compounded Bracketed Progesterone 1-40% in Medisca VersaPro Cream Base | Progesterone | VersaPro Cream Base | |
Stability of Prednisone in Oral Mix Suspending Vehicle | Prednisone | Oral Mix | |
Stability of Extemporaneously Compounded Piroxicam 10mg/mL Suspension with Acetate Buffer | Piroxicam | Oral Suspend | |
Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10mg/mL stored under refrigeration (4°C) for 70 days | Omeprazole | Oral Mix Dry Alka, SF | |
Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes | Naproxen | Oral Mix, Oral Mix, SF | |
Stability Studies on Naproxen Cream (potency-over-time only) | Naproxen | PLO Gel Mediflo30 | |
Stability of Extemporaneously-compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes | Nadolol | Oral Mix | |
Prospective, Randomized, Double-Blind, Placebo-Controlled Study on Efficacy of Copaiba Oil in Silicone-Based Gel to Reduce Scar Formation | N/A | CopaSil | |